IGM Biosciences (IGMS) Investor Presentation - Slideshow

Global Leaders in IgM Antibodies Corporate Overview September 2022 Forward-looking statements This presentation contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect the current views of IGM Biosciences, Inc. (the "Company," "we" or "our") with respect to the Company's future financial condition, results of operations, business strategy, expectations, milestones and plans, including our expectations regarding the transaction with Sanofi, ...